Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

Announcement on Obtaining Korea Pharmaceutical Raw Material Registration Certificate for Drug Substance Vonoprazan Fumarate by its Wholly-owned Subsidiary

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Korea Pharmaceutical Raw Material Registration Certificate for Drug Substance Vonoprazan Fumarate by its Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment